➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Colorcon
Medtronic
Dow
AstraZeneca

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

Litigation Details for Purdue Pharma L.P. v. IMPAX Laboratories, Inc. (S.D.N.Y. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Purdue Pharma L.P. v. IMPAX Laboratories, Inc.
The small molecule drug covered by the patents cited in this case is   Get Started for $10 .

Details for Purdue Pharma L.P. v. IMPAX Laboratories, Inc. (S.D.N.Y. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-04-08 1 States Patent l\lo. 7,776,314 entitled “ABUSE-PROOFED DOSAGE SYSTEl\/l" (“the ’314 patent”), including…and an exclusive licensee of United States Patent No. 7,776,314 identified in paragraph 19 below. Purdue…Grunenthal is the owner of United States Patent No. 7,776,314 identified in paragraph 19 below. THE PARTIES…the ’3l4 patent from Grtlnenthal, with the right to enforce the ’314 patent. The 7314 patent is listed…ACTION l. This is an action for patent infringement arising under the patent laws Of the Unitcd States, & External link to document
2013-09-10 110 invention date for the claims of U.S. Patent No. 6,488,963 Patent that is earlier than June 26, 1996; 2… 2. Plaintiffs stipulate that European Patent Application 0 661 045 ("the EP '045 Publication") was published…1995, and is prior art to the claims of the '963 Patent under 35 U.S.C. § 102(a); 3. and Plaintiffs will…the EP '045 Publication is prior art to the '963 Patent at trial. (Signed by Judge Sidney H. Stein on 9…2011 6 December 2013 1:11-cv-02400 830 Patent None District Court, S.D. New External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Merck
Colorcon
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.